Northwire Canada EditionTuesday, July 14, 2026
Sign inSubscribe
Northwire
⌕
ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0% MGG 0.310 −6.1% BUFF 0.770 +2.7% TKO 11.18 +12.2% MINK 0.105 +0.0% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0% MGG 0.310 −6.1% BUFF 0.770 +2.7% TKO 11.18 +12.2% MINK 0.105 +0.0%
Regulatory

Tilray seeks extension to meet Nasdaq requirements

By The Northwire Desk — AI Analysis Aug 14, 2025 · 15:39 TLRY · 1.72 Tilray Brands Inc
TLRY · Price

Executive Summary

  • Tilray Brands Inc. has submitted an application to Nasdaq requesting an extension to regain compliance with listing standards regarding its share price.
  • The company is evaluating strategic options to address its capital structure and maintain adherence to Nasdaq's continued listing requirements, specifically considering a stockholder-approved reverse stock split.
  • CEO Irwin Simon highlighted recent appreciation in trading levels following political developments regarding cannabis rescheduling, asserting investor confidence in the company's diversified global platform.

Key Details

  • Action Taken: Submission of an application to Nasdaq Stock Market requesting an extension to meet listing standards.
  • Specific Requirement: Compliance with Nasdaq’s listing standards regarding the price per share.
  • Strategic Options Under Evaluation:
    • Stockholder-approved reverse stock split.
    • Other unspecified options to address capital structure.
  • Management Commentary:
    • CEO Irwin Simon noted that trading levels have appreciated in recent weeks.
    • Attribution for market reaction: President Trump's review of cannabis rescheduling.
    • Company positioning: Leader in cannabis, beverage, and wellness with a diversified global platform.
    • Strategic goal: Building the future of consumer goods and creating value through innovation at global scale.
    • Timeline implication: The extension request provides additional time for the market to demonstrate confidence in the long-term strategy.

Notable Quotes

  • "Tilray's trading levels have appreciated in recent weeks following President Trump's review of cannabis reschedulling. We believe this market reaction reflects investors' confidence in Tilray's diversified global platform and our ability to capitalize on a more favourable regulatory environment." — Irwin Simon, CEO
  • "Tilray has multiple options to meet Nasdaq's requirements and, with this extension request, we are giving the market additional time to demonstrate its confidence in our long-term strategy." — Irwin Simon, CEO
Read the original news release →

More from Tilray Brands Inc

Jun 29, 2026 · 17:09

Strategic Canadian medical cannabis platform add-on; financials undisclosed as stock digests post-BrewDog integration headwinds.

M&A / Property Jun 24, 2026 · 08:13

BrewDog summer promos fail to offset sustained post-acquisition valuation compression and guidance caution.

Production / Operations Jun 22, 2026 · 09:50

BrewDog Bars Draw Record Fan Turnout as Global Tournament Fever Drives Double-Digit Growth

Production / Operations Jun 18, 2026 · 07:30

Breckenridge Distillery Releases Limited Single Barrel Bourbon Collection

Other Jun 18, 2026 · 07:00

Incremental SKU additions to a beverage portfolio already priced for execution risk; no near-term financial inflection.

Other Jun 17, 2026 · 07:00

BrewDog integration and beverage margin pressure overshadow cannabis growth; stock discounts guidance achievability

Other